Webbläsaren som du använder stöds inte av denna webbplats. Alla versioner av Internet Explorer stöds inte längre, av oss eller Microsoft (läs mer här: * https://www.microsoft.com/en-us/microsoft-365/windows/end-of-ie-support).

Var god och använd en modern webbläsare för att ta del av denna webbplats, som t.ex. nyaste versioner av Edge, Chrome, Firefox eller Safari osv.

Comparability : Manufacturing, characterization and controls, report of a UK Regenerative Medicine Platform Pluripotent Stem Cell Platform Workshop, Trinity Hall, Cambridge, 14-15 September 2015

In English

Författare

  • David J. Williams
  • Richard Archer
  • Peter Archibald
  • Ioannis Bantounas
  • Ricardo Baptista
  • Roger Barker
  • Jacqueline Barry
  • Florence Bietrix
  • Nicholas Blair
  • Julian Braybrook
  • Jonathan Campbell
  • Maurice Canham
  • Amit Chandra
  • Gabor Foldes
  • Rudy Gilmanshin
  • Mathilde Girard
  • Erwin Gorjup
  • Zöe Hewitt
  • Paul Hourd
  • Johan Hyllner
  • Helen Jesson
  • Jasmin Kee
  • Julie Kerby
  • Nina Kotsopoulou
  • Stanley Kowalski
  • Chris Leidel
  • Damian Marshall
  • Louis Masi
  • Mark McCall
  • Conor McCann
  • Nicholas Medcalf
  • Harry Moore
  • Hiroki Ozawa
  • David Pan
  • Malin Parmar
  • Anne L. Plant
  • Yvonne Reinwald
  • Sujith Sebastian
  • Glyn Stacey
  • Robert J. Thomas
  • Dave Thomas
  • Jamie Thurman-Newell
  • Marc Turner
  • Loriana Vitillio
  • Ivan Wall
  • Alison Wilson
  • Jacqueline Wolfrum
  • Ying Yang
  • Heiko Zimmerman
Visa allt

Summary, in English

This paper summarizes the proceedings of a workshop held at Trinity Hall, Cambridge to discuss comparability and includes additional information and references to related information added subsequently to the workshop. Comparability is the need to demonstrate equivalence of product after a process change; a recent publication states that this 'may be difficult for cell-based medicinal products'. Therefore a well-managed change process is required which needs access to good science and regulatory advice and developers are encouraged to seek help early. The workshop shared current thinking and best practice and allowed the definition of key research questions. The intent of this report is to summarize the key issues and the consensus reached on each of these by the expert delegates.

Publiceringsår

2016-07-01

Språk

Engelska

Sidor

483-492

Publikation/Tidskrift/Serie

Regenerative Medicine

Volym

11

Issue

5

Dokumenttyp

Artikel i tidskrift

Förlag

Future Medicine Ltd.

Ämne

  • Neurosciences

Nyckelord

  • Advice
  • Comparability
  • Human pluripotent stem cell derived
  • Manufacturing
  • Quality
  • Regulatory

Status

Published

Forskningsgrupp

  • Developmental and Regenerative Neurobiology

ISBN/ISSN/Övrigt

  • ISSN: 1746-0751